RxDoctor Payments Data

Robert Midence, MD

Geriatric Medicine · Sebring, FLNPI 1578581112

Payments from drug & device makers

$998in general payments, 2019–2025

Across 44 payments — averaging $22.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$390
  • Lilly USA, LLC$204
  • Intuitive Surgical$103
  • Corcept Therapeutics$57
  • Exact Sciences$50
  • Abbott$43
  • plus $149 from 7 others

What the payments were for

  • Food & beverage$998100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$998 in reported general payments places this provider in the 70th percentile of 305 geriatric medicine providers in Florida.

See all geriatric medicine providers in Florida

Medicare billing

Part B allowed, 2024
$270,356
Medicare patients
510
Services billed
3,537

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban153$187,174
MounjaroTirzepatide83$118,715
JardianceEmpagliflozin69$96,022
OzempicSemaglutide63$80,343
JanuviaSitagliptin Phosphate52$66,868
RybelsusSemaglutide25$42,406
XareltoRivaroxaban29$34,369
TrulicityDulaglutide14$28,788
FarxigaDapagliflozin Propanediol27$26,089
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$23,373
JanumetSitagliptin Phos/Metformin Hcl26$16,487
SymbicortBudesonide/Formoterol Fumarate34$16,338
Janumet XrSitagliptin Phos/Metformin Hcl11$14,420
Lantus SolostarInsulin Glargine,hum.Rec.Anlog63$11,464
Repatha SyringeEvolocumab14$10,807

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$27$187,174153 claims
Lilly USA, LLCMounjaro, Trulicity$204$147,50397 claims
Novo NordiskOzempic, Rybelsus$390$122,74988 claims
Boehringer IngelheimJardiance$19$96,02269 claims
GSKTrelegy Ellipta$15$23,37328 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 305 geriatric medicine providers in Florida.

Other geriatric medicine in Sebring

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →